Takeda to sell nonprescription drug unit to Blackstone

Takeda to sell nonprescription drug unit to Blackstone

Photo taken Aug. 24, 2020, in Tokyo shows Alinamin vitamin pills sold by Takeda Consumer Healthcare Co. Takeda Pharmaceutical Co. said the same day it will sell the over-the-counter medicine unit for around 242 billion yen ($2.3 billion) to U.S. investment fund Blackstone Group Inc.

Takeda to sell nonprescription drug unit to Blackstone

Takeda to sell nonprescription drug unit to Blackstone

Photo taken Aug. 24, 2020, in Tokyo shows Alinamin vitamin pills sold by Takeda Consumer Healthcare Co. Takeda Pharmaceutical Co. said the same day it will sell the over-the-counter medicine unit for around 242 billion yen ($2.3 billion) to U.S. investment fund Blackstone Group Inc.

Takeda to sell nonprescription drug unit to Blackstone

Takeda to sell nonprescription drug unit to Blackstone

Photo taken Aug. 24, 2020, in Tokyo shows Alinamin vitamin pills sold by Takeda Consumer Healthcare Co. Takeda Pharmaceutical Co. said the same day it will sell the over-the-counter medicine unit for around 242 billion yen ($2.3 billion) to U.S. investment fund Blackstone Group Inc.

Takeda to sell nonprescription drug unit to Blackstone

Takeda to sell nonprescription drug unit to Blackstone

Photo taken Aug. 24, 2020, in Tokyo shows Alinamin vitamin pills sold by Takeda Consumer Healthcare Co. Takeda Pharmaceutical Co. said the same day it will sell the over-the-counter medicine unit for around 242 billion yen ($2.3 billion) to U.S. investment fund Blackstone Group Inc.

Takeda to sell nonprescription drug unit to Blackstone

Takeda to sell nonprescription drug unit to Blackstone

Photo taken Aug. 24, 2020, in Tokyo shows Alinamin vitamin pills sold by Takeda Consumer Healthcare Co. Takeda Pharmaceutical Co. said the same day it will sell the over-the-counter medicine unit for around 242 billion yen ($2.3 billion) to U.S. investment fund Blackstone Group Inc.

Takeda to sell nonprescription drug unit to Blackstone

Takeda to sell nonprescription drug unit to Blackstone

Photo taken Aug. 24, 2020, in Tokyo shows Alinamin vitamin pills sold by Takeda Consumer Healthcare Co. Takeda Pharmaceutical Co. said the same day it will sell the over-the-counter medicine unit for around 242 billion yen ($2.3 billion) to U.S. investment fund Blackstone Group Inc.